John Koreth Selected Research

Photopheresis

1/2019

Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Koreth Research Topics

Disease

44	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 07/2007
33	Bronchiolitis Obliterans Syndrome 01/2023 - 04/2009
29	Neoplasms (Cancer) 03/2024 - 04/2008
16	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 05/2007
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 06/2009
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2024 - 01/2008
11	Leukemia 12/2023 - 05/2007
7	Multiple Myeloma 05/2024 - 02/2007
6	Lymphoma (Lymphomas) 01/2018 - 04/2008
4	Infections 01/2022 - 04/2012
4	Iron Overload 06/2012 - 05/2007
3	Cytokine Release Syndrome 01/2023 - 01/2021
3	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2019
3	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 11/2022 - 01/2019
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 01/2016
2	Cytopenia 05/2024 - 01/2021
2	Injection Site Reaction 12/2022 - 11/2017
2	Hematuria 11/2022 - 12/2020
2	Viremia 01/2022 - 05/2010
2	Inflammation (Inflammations) 11/2020 - 01/2018
2	Virus Diseases (Viral Diseases) 01/2020 - 08/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 09/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2017 - 04/2008
1	Residual Neoplasm 05/2024
1	Melanoma (Melanoma, Malignant) 03/2024
1	Mesothelioma 03/2024
1	Colorectal Neoplasms (Colorectal Cancer) 03/2024
1	Primary Myelofibrosis (Myelosclerosis) 12/2023
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 12/2023
1	Pathologic Complete Response 12/2023
1	Opportunistic Infections (Opportunistic Infection) 11/2023
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2023
1	Plasma Cell Leukemia 01/2023
1	Bronchiolitis Obliterans 12/2022
1	Epistaxis (Nosebleed) 11/2022
1	Hypotension (Low Blood Pressure) 11/2022
1	COVID-19 01/2021
1	Dysbiosis 11/2020

Drug/Important Bio-Agent (IBA)

18	Tacrolimus (Prograf)FDA LinkGeneric 01/2024 - 07/2007
13	Interleukin-2 (IL2)IBA 01/2023 - 12/2011
12	Sirolimus (Rapamycin)FDA Link 01/2020 - 07/2007
9	Methotrexate (Mexate)FDA LinkGeneric 01/2024 - 07/2009
7	Bortezomib (Velcade)FDA Link 03/2019 - 10/2009
6	fludarabineIBA 02/2024 - 04/2008
6	Busulfan (Busulfex)FDA Link 02/2024 - 04/2008
6	SteroidsIBA 01/2023 - 05/2013
5	VaccinesIBA 12/2022 - 09/2009
5	AntigensIBA 11/2020 - 09/2013
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 01/2018
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2022 - 09/2009
4	Proteins (Proteins, Gene)FDA Link 07/2016 - 12/2009
3	CytokinesIBA 01/2022 - 09/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 01/2018
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 06/2013
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 09/2010
3	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 05/2010
2	Lenalidomide (CC 5013)FDA Link 05/2024 - 01/2019
2	venetoclaxIBA 01/2024 - 12/2021
2	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 06/2014
2	Chimeric Antigen ReceptorsIBA 01/2023 - 03/2015
2	Alemtuzumab (Campath)FDA Link 01/2023 - 05/2013
2	ibrutinibIBA 12/2021 - 11/2014
2	IpilimumabIBA 10/2021 - 07/2016
2	Natalizumab (Tysabri)FDA Link 05/2021 - 01/2021
2	InterferonsIBA 12/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 06/2012
2	Phosphotransferases (Kinase)IBA 01/2020 - 12/2008
2	trans-crotonin (CTN)IBA 03/2019 - 01/2019
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2019 - 05/2009
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 11/2016
2	AntibodiesIBA 12/2017 - 03/2015
2	Calcineurin InhibitorsIBA 09/2013 - 09/2009
2	Ferritins (Ferritin)IBA 06/2012 - 06/2011
2	IronIBA 06/2012 - 06/2011
1	Prostaglandins FIBA 05/2024
1	MesothelinIBA 03/2024
1	EpitopesIBA 03/2024
1	Interleukin-18 (Interleukin 18)IBA 03/2024
1	Azacitidine (5 Azacytidine)FDA Link 01/2024
1	KIR ReceptorsIBA 12/2023
1	ixazomibIBA 01/2023
1	ChromatinIBA 12/2022
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Progesterone FDA LinkGeneric 01/2021

Therapy/Procedure

54	Hematopoietic Stem Cell Transplantation 01/2024 - 05/2007
36	Therapeutics 03/2024 - 02/2007
26	Transplantation 12/2023 - 05/2007
21	Stem Cell Transplantation 02/2024 - 02/2007
18	Cell Transplantation 05/2024 - 08/2017
8	Homologous Transplantation 01/2023 - 04/2008
3	Autologous Transplantation 01/2019 - 02/2007
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2016 - 07/2009
2	Immunotherapy 01/2022 - 09/2009
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2020 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2018 - 02/2007
1	Length of Stay 01/2021
1	Donor Selection 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021